If you need more lookups,
subscriptions start at $34 USD/month.
Bryan Sepulveda Location
United States
Bryan Sepulveda Work
Head of Global Medical Affairs @ (March 2024 - Present)
Senior Director Evidence Generation Strategy and Scientific Communications @ (August 2022 - May 2024)
Senior Director Global Medical Affairs @ (May 2021 - March 2022)
Director, Medical Affairs and Scientific Communications @ (January 2020 - May 2021)
VP, Medical and Scientific Services @ (April 2018 - January 2020)
Senior Scientific Director @ (July 2016 - April 2018)
Scientific Director @ (November 2013 - July 2016)
Adjunct Lecturer @ (January 2011 - December 2012)
PhD Student @ (August 2009 - April 2013)
Market Access Consultant @ (March 2008 - April 2013)
Bryan Sepulveda Education
Mount Sinai School of Medicine of New York University
PhD (Neuroscience)
2009-2013
Mount Sinai School of Medicine of New York University
MS (Neuroscience)
2006-2008
Cornell University
BS (Biology, Applied Economics and Management)
2002-2006
Bryan Sepulveda Skills
Molecular Biology
Confocal Microscopy
Lifesciences
Launch Experience
Data Analysis
Strategic Communications
Biotechnology
Oncology
Biochemistry
Market Access
Pharmaceutical Industry
Life Sciences
Cell Culture
Cell Biology
Team Leadership
Strategy
Scientific Communications
Healthcare Consulting
Neuroscience
Medical Education
Bryan Sepulveda Summary
Bryan Sepulveda, based in United States, is currently a Head of Global Medical Affairs at Sirtex Medical Limited. Bryan Sepulveda brings experience from previous roles at Sirtex Medical Limited, Astellas Pharma and Chameleon Communications International. Bryan Sepulveda holds a 2009 - 2013 PhD in Neuroscience @ Mount Sinai School of Medicine of New York University. With a robust skill set that includes Molecular Biology, Confocal Microscopy, Lifesciences, Launch Experience, Data Analysis and more. Bryan Sepulveda has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Bryan Sepulveda?
Find contact details for 700 million professionals.